Vasileios Kyttaris is a Rheumatology/Immunology physician affiliated with Beth Israel Deaconess Medical Center. OpenAlex indexes 166 publications with 7,010 citations (h-index 47).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
110 Francis St
Suite 4b
Boston, MA 022155501
Telephone
617-632-8658Registry record last updated 26 Aug 2008.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20252 payments
- AstraZeneca UK LimitedProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
47.4%Folate Analog Metabolic Inhibitor14.5%Methotrexate100%Part D≥32 patientsTNF inhibitor11%Enbrel Sureclick47%Humira(Cf) Pen31%Humira Pen13%Cyltezo(Cf) Pen9%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
18.8%Corticosteroid16%Prednisone100%Part D≥40 patientsAminosalicylate2.7%Sulfasalazine Dr55%Sulfasalazine45%Part D<11 patientsNervous system
11.5%Nonsteroidal Anti-inflammatory Drug4.2%Meloxicam100%Part D≥12 patientsGabapentinoids3.1%Gabapentin55%Pregabalin46%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2008–2016 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiation
Proceedings of the National Academy of Sciences
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Matcheri Keshavan, MD
Beth Israel Deaconess Medical Center
Connie Tsao, MD
Beth Israel Deaconess Medical Center
Donald Cutlip, MD
Beth Israel Deaconess Medical Center
Robert Yeh, MD
Beth Israel Deaconess Medical Center
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”